Table 1.
Study | Donor source | Immuno-suppression | Age at transplantation | Time to recurrencea | Concurrent disease? | Plasma exchange? | Rituximab dose | Comments |
---|---|---|---|---|---|---|---|---|
Hristea [8] | LRD | Pred; Tac; MMF; Basiliximab | 22 years | 2 days | None | Yes, partial response | 375 mg/m2 once weekly; two doses | Complete remission; PE and rituximab were used concomitantly |
Gossmann [10] | Post-mortal | Pred; Tac; MMF; ATG | 48 years | 40 days | None | Yes, no response | 375 mg/m2 once weekly; two doses | Complete remission after rituximab |
Meyer [11] | LRD | Pred; Tac; MMF; Basiliximab | 31 years | 2 months | None | Yes, preemptive, partial response | 375 mg/m2 once weekly; three doses | Partial remission after rituximab |
El-Firjani [13] | LRD | Pred; Tac; MMF; ATG | 48 years | 1 month | None | Yes, no response | 375 mg/m2; six doses in 8 weeks | No remission after rituximab |
Kamar [9] | Post-mortal | Pred; CsA; MMF; Basiliximab | 25 years | 1 day | None | Yes, preemptive, partial response | 375 mg/m2 once weekly; two doses | Complete remission; however, PE and rituximab were used concomitantly; A relapse was also treated with rituximab and PE, proteinuria had already decreased significantly before rituximab treatment |
Post-mortal | Pred; CsA; MMF; Basiliximab | 46 years | 1 day | None | Yes, no response | 375 mg/m2 once weekly; four doses | No remission after rituximab | |
Yabu [12] | Post-mortal | Pred; Tac; MMF | 41 years | 3 days | None | Yes, partial response | 1000 mg fortnightly; two doses | No remission after rituximab |
LRD | Pred; Tac; MMF; ATG | 43 years | 2 months | None | Yes, >50% decrease in proteinuria, no remission | 375 mg/m2 once weekly; four doses | No remission after rituximab | |
LRD | Total lymphoid irradiation; ATG; CsA; MMF; pred | 41 years | <14 days | None | Yes, no response | 375 mg/m2 once weekly; six doses | No remission after rituximab | |
LRD | JAK3 inhibitor; MMF; Pred | 47 years | 1 month | None | Yes, partial response | 375 mg/m2 once weekly; six doses | No remission after rituximab |
aExact time to recurrence not available.
Definitions: complete remission = proteinuria <0.2 g/24 h; partial remission/response = proteinuria between 0.2 g/24 h and 2.0 g/24 h.
LRD = living related donor; ATG = anti-thymocyte globulin; Aza = azathioprine; CsA = Cyclosporine; MMF = mycophenolate mofetil; Pred = prednisone; Tac = tacrolimus; PE = plasma exchange.